Company news

hVIVO plc news in 2023

hVIVO plc's news releases, calls and decks from 2023, newest first.

View company

£16.8m RSV contract & Trading ahead of guidance

December 13, 2023

Positive results from flu human challenge study

October 5, 2023

Exercise of Warrants

September 1, 2023

Plans for a new larger state-of-the-art facility

August 29, 2023

Flu B challenge model

July 25, 2023

hMPV human challenge model

June 28, 2023

Director dealings

June 14, 2023

Annual Report and Notice of AGM

April 28, 2023

FDA Breakthrough and Fast Track for US biotech

April 26, 2023

HVIVO reveals audited results for "transformational" 2022

April 25, 2023

Presentation at World Vaccine Congress

March 29, 2023

Omicron human challenge model update

March 16, 2023

Second Price Monitoring Extn

February 6, 2023

HVIVO announces "record results" for 2022

January 26, 2023

Price Monitoring Extension

January 25, 2023

EUR3.2m Venn contract with global pharma client

January 17, 2023

£5.2m RSV contract and Notice of Trading update

January 4, 2023

Calls in 2023

Decks in 2023